Vitekta

País: Nova Zelanda

Idioma: anglès

Font: Medsafe (Medicines Safety Authority)

ingredients actius:

Elvitegravir 85mg;  ;  ;  ;  

Disponible des:

Gilead Sciences (NZ)

Designació comuna internacional (DCI):

Elvitegravir 85 mg

Dosis:

85 mg

formulario farmacéutico:

Film coated tablet

Composición:

Active: Elvitegravir 85mg         Excipient: Croscarmellose sodium Hyprolose Lactose monohydrate Magnesium stearate Microcrystalline cellulose Opadry green 85F91203 Sodium laurilsulfate

tipo de receta:

Prescription

Fabricat per:

Gilead Sciences Inc

indicaciones terapéuticas:

Indicated for the treatment of HIV-1 infection in antiretroviral treatment-experienced adults and adolescents when co-administered with a ritonavir-boosted protease inhibitor and other antiretroviral therapy.

Resumen del producto:

Package - Contents - Shelf Life: Bottle, plastic, HDPE with child resistant PE cap - 30 tablets - 24 months from date of manufacture stored at or below 25°C

Data d'autorització:

2013-11-04